Real-world outcomes in patients with AML and MDS treated with Azacitidine

被引：0
|
作者：
Prusak, E. [1 ]
Lawes, M. [2 ]
Collins, A. [2 ]
机构：
[1] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[2] Norfolk & Norwich Univ Hosp, Haematol, Norwich, Norfolk, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷
关键词：
AML; Azacitidine; mds;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH18-PO-0
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD OUTCOMES AMONG AML PATIENTS TREATED WITH DECITABINE OR AZACITIDINE
    Smith, B.
    Beach, C.
    Mahmoud, D.
    Weber, L.
    Henk, H.
    HAEMATOLOGICA, 2013, 98 : 19 - 19
  • [2] Real-world outcomes among AML patients treated with decitabine or azacitidine
    Smith, B. D.
    Beach, C. L.
    Mahmoud, D.
    Weber, L.
    Henk, H.
    LEUKEMIA RESEARCH, 2013, 37 : S109 - S109
  • [3] Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'
    Mozessohn, Lee
    Cheung, Matthew C.
    Mittmann, Nicole
    Earle, Craig C.
    Liu, Ning
    Buckstein, Rena
    LEUKEMIA & LYMPHOMA, 2020, 61 (06) : 1445 - 1454
  • [4] Real-World Outcome and Prognostic Factors in MDS Patients Treated with Azacitidine-A Retrospective Analysis
    Wisniewski, Kamil
    Pruszczyk-Matusiak, Katarzyna
    Pula, Bartosz
    Lech-Maranda, Ewa
    Gora-Tybor, Joanna
    CANCERS, 2024, 16 (07)
  • [5] REAL WORLD USE OF AZACITIDINE IN ELDERLY PATIENTS WITH MDS/AML-THE SCOTTISH EXPERIENCE
    Lund, K.
    Drummond, M.
    Eynaud, P.
    Fitzsimons, K.
    Olaiya, A.
    Copland, M.
    HAEMATOLOGICA, 2013, 98 : 309 - 310
  • [6] Real-World Outcomes of IDH Mutant AML Patients Treated with or without IDH Inhibitors
    Al Sbihi, Ali
    Reddy, Sushmitha Nanja
    Dhillon, Vikram
    Lalo, Enxhi
    Ramos, Harry
    Khan, Abdul Moiz
    Balasubramanian, Suresh Kumar
    BLOOD, 2022, 140 : 6189 - 6190
  • [7] Efficacy and Safety Analysis of Venetoclax Combined with Azacitidine in Real-World Treatment of Patients with AML
    Huang, Xin
    Deng, Chengxin
    Li, Minming
    Lu, Zesheng
    Wu, Ping
    Luo, Qiong
    Geng, Suxia
    Zeng, Lingji
    Wang, Yulian
    Zhou, Hui
    Weng, Jianyu
    Du, Xin
    BLOOD, 2023, 142
  • [8] Selinexor in Combination with Azacitidine ( AZA) in Patients with Myelodysplastic Syndrome (MDS): A Real-World Retrospective Study
    Zhou, Huifen
    Wu, Xiaoxia
    Yang, Zhen
    Zhang, Xinhui
    Lu, Shenqi
    Wu, Depei
    Miao, Miao
    BLOOD, 2023, 142
  • [9] Cytogenetic peripheral blood monitoring in azacitidine treated patients with high-risk MDS/sAML: A monocentric real-world experience
    Braulke, Friederike
    Schweighofer, Adrian
    Schanz, Julie
    Shirneshan, Katayoon
    Ganster, Christina
    Pollock-Kopp, Beatrix
    Leha, Andreas
    Haase, Detlef
    LEUKEMIA RESEARCH, 2023, 124
  • [10] Invasive Fungal Infections in Patients with High-Risk MDS and AML Treated with Azacitidine
    Pomares, Helena
    Arnan, Montserrat
    Sanchez-Ortega, Isabel
    Sureda, Anna
    Duarte, Rafael F.
    BLOOD, 2015, 126 (23)
12345